PharmaCielo Ltd. (PCLO.V)
CAD 0.09
(-10.0%)
CAD 0.09
(-10.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -1.36 Million CAD | -368.91% |
| 2022 | 827.05 Thousand CAD | 119.2% |
| 2021 | -4.3 Million CAD | 36.63% |
| 2020 | -6.79 Million CAD | -309.69% |
| 2019 | -1.65 Million CAD | -153.9% |
| 2018 | -653.62 Thousand CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 314.93 Thousand CAD | 160.99% |
| 2024 Q1 | -450.5 Thousand CAD | 80.26% |
| 2023 Q4 | -2.28 Million CAD | -553.49% |
| 2023 Q2 | -609.25 Thousand CAD | -214.93% |
| 2023 FY | -2.22 Million CAD | -368.91% |
| 2023 Q3 | -349.18 Thousand CAD | 42.69% |
| 2023 Q1 | -193.45 Thousand CAD | -199.19% |
| 2022 Q2 | 834.81 Thousand CAD | 710.0% |
| 2022 Q4 | 195.03 Thousand CAD | 163.77% |
| 2022 FY | 827.05 Thousand CAD | 119.2% |
| 2022 Q1 | 103.06 Thousand CAD | 118.54% |
| 2022 Q3 | -305.85 Thousand CAD | -136.64% |
| 2021 Q1 | -1.01 Million CAD | 83.43% |
| 2021 FY | -4.3 Million CAD | 36.63% |
| 2021 Q4 | -555.83 Thousand CAD | 58.81% |
| 2021 Q3 | -1.34 Million CAD | -67.09% |
| 2021 Q2 | -807.7 Thousand CAD | 20.25% |
| 2020 Q4 | -6.11 Million CAD | -795.11% |
| 2020 Q3 | -682.82 Thousand CAD | -547.84% |
| 2020 Q1 | -156.72 Thousand CAD | 95.87% |
| 2020 Q2 | 152.46 Thousand CAD | 197.29% |
| 2020 FY | -6.79 Million CAD | -309.69% |
| 2019 Q1 | -906.22 Thousand CAD | 0.0% |
| 2019 FY | -1.65 Million CAD | -153.9% |
| 2019 Q4 | -3.79 Million CAD | -277.8% |
| 2019 Q3 | 2.13 Million CAD | 502.92% |
| 2019 Q2 | -529.38 Thousand CAD | 41.58% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 FY | -653.62 Thousand CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5499.00 CAD | 24992.471% |
| CanadaBis Capital Inc. | 11.78 Million CAD | 111.616% |
| Decibel Cannabis Company Inc. | 41.85 Million CAD | 103.27% |
| Delivra Health Brands Inc. | 6.39 Million CAD | 121.391% |
| Entourage Health Corp. | 3.7 Million CAD | 136.919% |
| Lifeist Wellness Inc. | 5.34 Million CAD | 125.613% |
| Cannara Biotech Inc. | 27.23 Million CAD | 105.027% |
| Medicure Inc. | 13.98 Million CAD | 109.785% |
| Rubicon Organics Inc. | 13.14 Million CAD | 110.417% |
| BioSyent Inc. | 25.14 Million CAD | 105.444% |
| Voyageur Pharmaceuticals Ltd. | -2185.00 CAD | -62547.002% |